| GTO ID | GTC3210 |
| Trial ID | NCT05580796 |
| Disease | Solid Tumor |
| Altered gene | TAA |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | KSH01 TCR-T cells |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Investigator Initiated Clinical Trial on the Tolerance, Safety and Preliminary Efficacy of KSH01-TCRT Injection in Solid Tumor Subjects |
| Year | 2022 |
| Country | China |
| Company sponsor | TCRx Therapeutics Co.Ltd |
| Other ID(s) | KSH01-R02-101 |
| Cohort 1 | |||||||||
|
|||||||||